areas expanded to encompass large areas adjacent to the DMZ from Ganghwa to Yanggu Counties. P. vivax malaria also occurred in Goseong County located east of the Taebaeck Mountain Range during this period. However, malaria occurrence in Goseong County might have resulted from infected mosquitoes originating from the adjacent DPRK, and not from direct expansion from neighboring Yanggu County. Since 2001, the occurrence of malaria cases had decreased in most cities/counties located in the malaria-risk areas with reduction of the total annual incidence. However, P. vivax malaria continues to be problematic in the northwestern part of ROK including the cities of Gimpo, Incheon, Goyang, and Paju, and in Ganghwa and Yeoncheon Counties. Increase of the total annual incidence that has occurred since 2005 has been mainly due to the increased number of cases in these locales, which might be influenced by the malaria situation in DPRK. In the mid-2000s, regional incidences in some areas of the southwestern part of DPRK adjacent to the DMZ -a region harboring many rice fields that can be breeding grounds for mosquitoes-remained as high or even higher than in 2000 and 2001 when the number of P. vivax malaria cases in DPRK reached the highest peak ever [13] [14] [15] , which might have influenced the rapid increase of malaria cases in the northwestern part of ROK. In contrast to the malaria situation during the 1990s, few malaria cases occurred in the northeastern part of ROK. Besides the direct influence from DPRK, local transmission within ROK has been implicated in the more recent cases. Many cases occurred in Incheon and Goyang Cities that are more than 30 km away from the DMZ, and civilian cases, most of which generally reside south of the Civilian Control Line, have exceeded 60% of the total annual cases since 2003. Focal outbreaks have not been reported in Seoul or other areas that are not adjacent to the malaria-risk areas. All the cases diagnosed in Seoul or southern provinces involved persons who has lived or traveled in the malaria-risk areas.
P. vivax malaria in ROK has presented a typical unstable malaria pattern (Fig. 3) [7] [8] [9] [10] . Most malaria cases in civilians, who, in contrast to the military personnel, did not receive chemoprophylaxis, occurred from June through September with a unimodal peak. Ten-day incidence showed its peak in July and August. However, in 2005 and 2006, the incidence displayed a wider peak extending to early September, which was unusual considering the seasonal incidence pattern of the previous years [9, 10] . The increase in P. vivax malaria cases during September and October in 2005 and 2006 means that early primary attack cases via short incubation period actively occurred, implying a longer transmission period during these years.
To determine the exact period of the first primary attack cases, P. vivax malaria cases with a short incubation period among ROK Army military patients who had been exposed to malaria for only 1 season, having begun their military service in the same year or after November of the previous year, were examined. The Total   1993  1  0  0  1  1994  18  1  2  21  1995  88  12  7  107  1996  287  25  46  358  1997  1,155  207 b results showed that the first cases of early primary attack with a short incubation period occurred in early June (Fig. 4 ) [7] . These cases were attributed to mosquitoes that became infected from P. vivax malaria patients, who were exposed and transmitted in the previous year, in April of the current year. Therefore, the earliest cases would be transmitted from mosquitoes to humans in mid-May of the same year with symptoms being observed in early June. A large number of early primary attack cases began to occur from late July onwards. On the other hand, cases of the first late primary attack cases among veterans via a long incubation period mainly occurred during the first transmission season after their discharge, with the peak apparent between midJune and mid-August ( Fig. 5 ) [10] . This pattern was quite similar to that observed during the Korean War [4] . The basic bio- b logical characteristics of P. vivax with regard to relapse or late primary attack have remained the same for several decades on the Korean Peninsula.
To cope with epidemic malaria among various military units and to reduce spread to civilian populations, chemoprophylaxis was initiated among military personnel assigned to areas deemed to be high-risk for malaria in 1997. Chemoprophylaxis has involved hydroxychloroquine (HCQ), which is an analogue of chloroquine (CQ) with equivalent activity against malaria to CQ, followed by presumptive anti-relapse therapy with primaquine (PQ). The chemoprophylaxis program was expanded annually from approximately 16,000 soldiers in 1997 to 200,000 soldiers in 2005 (Table 2 ) [16] . Decreased incidence of P. vivax malaria in the ROK military was attributed to the annual expansion of chemoprophylaxis in high-risk malaria areas, especially since 1999. Prior to the initiation of chemoprophylaxis, soldier patients accounted for > 80% of all malaria cases in ROK (Table  3) . With the introduction of chemoprophylaxis, the proportion of military cases out of the total annual cases declined to 67% in 1997 and to 24% in 2002. From 1999 through 2002, the prevalence of malaria in the military population began to decrease 1-2 weeks after the initiation of chemoprophylaxis in early June or mid-May. This finding was different that the steadily increasing cases of malaria cases among civilians not provided with (Table 3 ) [16] .
Until 1997, > 90% of the total military cases occurred in areas of highest incidence including Yeoncheon, Paju, and Cheolwon Counties, where chemoprophylaxis was provided at the early stage. Cases in these regions gradually decreased to 56% by 2002 (Table 3 ) [16] . To calculate the chemoprophylactic efficacy, the occurrences of P. vivax malaria were compared between paired units with the similar risk for the exposure to infected Anopheline mosquitoes. In the treatment groups (those receiving chemoprophylaxis), a significant reduction in number of malaria cases was demonstrated while in their paired control group (no chemoprophylaxis) the number of cases increased significantly (Table 4 ) [16] . These results also demonstrate that even with partial chemoprophylaxis in malaria high-risk areas, the incidence of malaria decreased while expanding in adjacent counties where chemoprophylaxis was not provided.
Mass chemoprophylaxis of United States soldiers was done on a large scale during the Korean War (1950) (1951) (1952) (1953) . However, the scale of chemoprophylaxis undertaken for ROK Army personnel since 1997 is unprecedented. Despite the sizable reduction in malaria incidence among military personnel as a result of this campaign, efficacy of the mass chemoprophylaxis has been hampered by poor compliance. Among soldier patients, < 25% followed a regular chemoprophylaxis schedule (Table 5 ) [10] . Mass chemoprophylaxis with poor compliance increases the possibility of the occurrence of CQ-resistant strains of P. vivax. Since 2000, many prophylactic failure cases had been reported in those soldiers who followed chemoprophylactic schedule. In some, plasma concentrations of HCQ were high enough to exert anti-malarial activity, which signifies resistance to the HCQ prophylactic regimen (Fig. 7 ) [17] . The steady reduction of malaria cases among military personnel suggests the necessity of a scale-down of chemoprophylaxis. Moreover, the elimination time of parasitemia by CQ or HCQ treatment has been prolonged and 2 cases of CQ-resistant P. vivax were confirmed in ROK (Table 6 ) [18] . These cases represented the first report of CQresistant P. vivax from a temperate region of Asia. In the patients, parasitemias were reduced markedly, but not cleared, by HCQ administration.
Despite the epidemiological evidences linking DPRK to cases in ROK, DPRK was unwilling to confirm malaria occurrence in DPRK until 1998. However, it seems most likely that P. vivax malaria began to occur long before reemergence in ROK when considering various epidemiological data [19] . Official peak annual malaria incidence in DPRK was approximately 300,000 cases in 2001 (Fig. 8) [20] . This incidence might be an underestimate, since the official DPRK incidence has been confined to civilian cases, and most of the diagnosis has been made by clinical symptoms, not by microscopic confirmation.
Although the government of ROK had no irrefutable data on the DPRK malaria situation, it has donated materials and cash activity [20] . This assistance by ROK has likely been influential in the decrease of P. vivax malaria incidence in DPRK after 2001, which subsequently influenced the situation in ROK. In the spring of 2007, a large-scale presumptive anti-relapse therapy with PQ was performed on approximately 5 million DPRK individuals involving ROK assistance. The rapid reduction in the case incidence during September and October of 2007 in ROK seems related to this activity (Fig. 3 ) [10] . In 2000 and 2001, the number of P. vivax malaria cases in DPRK reached the highest peak ever, with nationwide prevalence of the disease except in the northern mountainous areas (Table 7) [13, 14, 20] . After 2001, the total number of annual cases dropped, with the geographic distribution shrinking to the southwestern part of DPRK that harbor many rice fields [15] . Monthly incidence of P. vivax malaria in DPRK showed a similar pattern to that in ROK with the peak in August (Fig. 9) [20] .
After reemergence in 1993, P. vivax malaria has been a constant presence in ROK. Even though the occurrence of malaria in ROK has been directly influenced by the malaria situation of DPRK, the possibility of local transmission within ROK has increased. Recently, the malaria transmission season became extended, possibly under the influence of global warming. CQsusceptibility of P. vivax has steadily decreased; the 2 cases of CQ-resistant P. vivax, which were the first report of CQ-resistant P. vivax from a temperate region of Asia, were reported in ROK. Continuous surveillance and monitoring are warranted to prevent further expansion of CQ-resistant P. vivax in ROK. [20] . 
